Does TORIPALIMAB Cause Pneumonitis? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Pneumonitis have been filed in association with TORIPALIMAB (LOQTORZI). This represents 2.1% of all adverse event reports for TORIPALIMAB.
28
Reports of Pneumonitis with TORIPALIMAB
2.1%
of all TORIPALIMAB reports
6
Deaths
5
Hospitalizations
How Dangerous Is Pneumonitis From TORIPALIMAB?
Of the 28 reports, 6 (21.4%) resulted in death, 5 (17.9%) required hospitalization, and 2 (7.1%) were considered life-threatening.
Is Pneumonitis Listed in the Official Label?
Yes, Pneumonitis is listed as a known adverse reaction in the official FDA drug label for TORIPALIMAB.
What Other Side Effects Does TORIPALIMAB Cause?
Myelosuppression (590)
Off label use (276)
White blood cell count decreased (144)
Anaemia (67)
Hypothyroidism (67)
Neutrophil count decreased (67)
Nausea (60)
Rash (59)
Vomiting (58)
Platelet count decreased (53)
What Other Drugs Cause Pneumonitis?
NIVOLUMAB (2,076)
PEMBROLIZUMAB (1,933)
METHOTREXATE (1,188)
PACLITAXEL (1,110)
CARBOPLATIN (975)
EVEROLIMUS (919)
IPILIMUMAB (891)
ATEZOLIZUMAB (842)
DURVALUMAB (827)
RITUXIMAB (747)
Which TORIPALIMAB Alternatives Have Lower Pneumonitis Risk?
TORIPALIMAB vs TORSEMIDE
TORIPALIMAB vs TOVIAZ
TORIPALIMAB vs TOVORAFENIB
TORIPALIMAB vs TOZINAMERAN
TORIPALIMAB vs TRABECTEDIN